Previous Article | Next Article 
Journal of Virology, March 2002, p. 2692-2702, Vol. 76, No. 6
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.6.2692-2702.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Human Immunodeficiency Virus Type 1 Nef Binds to Tumor Suppressor p53 and Protects Cells against p53-Mediated Apoptosis
Alison L. Greenway,1* Dale A. McPhee,1,2 Kelly Allen,1 Ricky Johnstone,3 Gavan Holloway,1 John Mills,2 Ahmed Azad,4 Sonia Sankovich,4 and Paul Lambert5
AIDS Cellular Biology Unit,1
AIDS Molecular Biology Unit, Macfarlane Burnet Centre for Medical Research,5
National Centre in HIV Virology Research, Fairfield, Victoria 3078,2
Peter MacCallum Cancer Institute, East Melbourne, Victoria 3002,3
Biomolecular Research Institute, Parkville, Victoria 3052, Australia4
Received 25 October 2001/
Accepted 17 December 2001
The nef gene product of human immunodeficiency virus type 1 (HIV-1) is important for the induction of AIDS, and key to its function is its ability to manipulate T-cell function by targeting cellular signal transduction proteins. We reported that Nef coprecipitates a multiprotein complex from cells which contains tumor suppressor protein p53. We now show that Nef interacts directly with p53. Binding assays showed that an N-terminal, 57-residue fragment of Nef (Nef 1-57) contains the p53-binding domain. Nef also interacted with p53 during HIV-1 infection in vitro. As p53 plays a critical role in the regulation of apoptosis, we hypothesized that Nef may alter this process. Nef inhibited UV light-induced, p53-dependent apoptosis in MOLT-4 cells, with Nef 1-57 being as effective as its full-length counterpart. The inhibition by Nef of p53 apoptotic function is most likely due its observed ability to decrease p53 protein half-life and, consequently, p53 DNA binding activity and transcriptional activation. These data show that HIV-1 Nef may augment HIV replication by prolonging the viability of infected cells by blocking p53-mediated apoptosis.
* Corresponding author. Mailing address: AIDS Cellular Biology Unit, Macfarlane Burnet Centre for Medical Research, Yarra Bend Rd., Fairfield, Victoria 3078, Australia. Phone: 61-3 9282 2112. Fax: 61-3 9282 2100. E-mail:
greenway{at}burnet.edu.au.
Journal of Virology, March 2002, p. 2692-2702, Vol. 76, No. 6
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.6.2692-2702.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Park, I.-W., He, J. J.
(2009). HIV-1 Nef-mediated inhibition of T cell migration and its molecular determinants. J. Leukoc. Biol.
86: 1171-1178
[Abstract]
[Full Text]
-
Mangino, G., Percario, Z. A., Fiorucci, G., Vaccari, G., Manrique, S., Romeo, G., Federico, M., Geyer, M., Affabris, E.
(2007). In Vitro Treatment of Human Monocytes/Macrophages with Myristoylated Recombinant Nef of Human Immunodeficiency Virus Type 1 Leads to the Activation of Mitogen-Activated Protein Kinases, I{kappa}B Kinases, and Interferon Regulatory Factor 3 and to the Release of Beta Interferon. J. Virol.
81: 2777-2791
[Abstract]
[Full Text]
-
Pauls, E., Senserrich, J., Clotet, B., Este, J. A.
(2006). Inhibition of HIV-1 replication by RNA interference of p53 expression. J. Leukoc. Biol.
80: 659-667
[Abstract]
[Full Text]
-
Roeth, J. F., Collins, K. L.
(2006). Human Immunodeficiency Virus Type 1 Nef: Adapting to Intracellular Trafficking Pathways. Microbiol. Mol. Biol. Rev.
70: 548-563
[Abstract]
[Full Text]
-
Schindler, M., Munch, J., Kirchhoff, F.
(2005). Human Immunodeficiency Virus Type 1 Inhibits DNA Damage-Triggered Apoptosis by a Nef-Independent Mechanism. J. Virol.
79: 5489-5498
[Abstract]
[Full Text]
-
Acheampong, E. A., Parveen, Z., Muthoga, L. W., Kalayeh, M., Mukhtar, M., Pomerantz, R. J.
(2005). Human Immunodeficiency Virus Type 1 Nef Potently Induces Apoptosis in Primary Human Brain Microvascular Endothelial Cells via the Activation of Caspases. J. Virol.
79: 4257-4269
[Abstract]
[Full Text]
-
MORDELET, E., KISSA, K., CRESSANT, A., GRAY, F., OZDEN, S., VIDAL, C., CHARNEAU, P., GRANON, S.
(2004). Histopathological and cognitive defects induced by Nef in the brain. FASEB J.
18: 1851-1861
[Abstract]
[Full Text]
-
Huang, M.-B., Jin, L. L., James, C. O., Khan, M., Powell, M. D., Bond, V. C.
(2004). Characterization of Nef-CXCR4 Interactions Important for Apoptosis Induction. J. Virol.
78: 11084-11096
[Abstract]
[Full Text]
-
Olszewski, A., Sato, K., Aron, Z. D., Cohen, F., Harris, A., McDougall, B. R., Robinson, W. E. Jr., Overman, L. E., Weiss, G. A.
(2004). Guanidine alkaloid analogs as inhibitors of HIV-1 Nef interactions with p53, actin, and p56lck. Proc. Natl. Acad. Sci. USA
101: 14079-14084
[Abstract]
[Full Text]
-
Fortin, J.-F., Barat, C., Beausejour, Y., Barbeau, B., Tremblay, M. J.
(2004). Hyper-responsiveness to Stimulation of Human Immunodeficiency Virus-infected CD4+ T Cells Requires Nef and Tat Virus Gene Products and Results from Higher NFAT, NF-{kappa}B, and AP-1 Induction. J. Biol. Chem.
279: 39520-39531
[Abstract]
[Full Text]
-
James, C. O., Huang, M.-B., Khan, M., Garcia-Barrio, M., Powell, M. D., Bond, V. C.
(2004). Extracellular Nef Protein Targets CD4+ T Cells for Apoptosis by Interacting with CXCR4 Surface Receptors. J. Virol.
78: 3099-3109
[Abstract]
[Full Text]
-
Percario, Z., Olivetta, E., Fiorucci, G., Mangino, G., Peretti, S., Romeo, G., Affabris, E., Federico, M.
(2003). Human immunodeficiency virus type 1 (HIV-1) Nef activates STAT3 in primary human monocyte/macrophages through the release of soluble factors: involvement of Nef domains interacting with the cell endocytotic machinery. J. Leukoc. Biol.
74: 821-832
[Abstract]
[Full Text]
-
Harrod, R., Nacsa, J., Van Lint, C., Hansen, J., Karpova, T., McNally, J., Franchini, G.
(2003). Human Immunodeficiency Virus Type-1 Tat/Co-activator Acetyltransferase Interactions Inhibit p53Lys-320 Acetylation and p53-responsive Transcription. J. Biol. Chem.
278: 12310-12318
[Abstract]
[Full Text]
-
Varin, A., Manna, S. K., Quivy, V., Decrion, A.-Z., Van Lint, C., Herbein, G., Aggarwal, B. B.
(2003). Exogenous Nef Protein Activates NF-kappa B, AP-1, and c-Jun N-Terminal Kinase and Stimulates HIV Transcription in Promonocytic Cells. ROLE IN AIDS PATHOGENESIS. J. Biol. Chem.
278: 2219-2227
[Abstract]
[Full Text]